- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0070245

About Darwin Platform Pharmaceuticals Limited
Data last updated:
Darwin Platform Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 03 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85191MH2012PLC235261. Its GSTIN is 27AAECD3888N1ZY (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Vasu Kumar and Rahul Jeewanlal Dhote.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.84 Cr. For the same year it recorded a net profit of ₹57.73 Lakh (net margin 2.2%) and EBITDA of ₹1.43 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 211% over three years and 163% over five years.
As per MCA filings, the company has open charges of ₹5 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 3 cases are pending.
Darwin Platform Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0070245). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website darwinpharma.in.
Company details
Recognitions & Rankings of Darwin Platform Pharmaceuticals
Contact details
Darwin Platform Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is darwinpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH – Wing Unit No. 127 Ansa Industrial Estate Saki Vihar Road Saki Naka Andheri (Eas, T), Mumbai, Maharashtra, India – 400072
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Darwin Platform Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Darwin Platform Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Darwin Platform Pharmaceuticals Limited, buy the company report.
Financials of Darwin Platform Pharmaceuticals Limited
FY 2024 filings availableDarwin Platform Pharmaceuticals Limited reported revenue of ₹25.84 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 163% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Darwin Platform Pharmaceuticals Limited, buy the company report.
Board of directors of Darwin Platform Pharmaceuticals Limited
Darwin Platform Pharmaceuticals has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Pincha Also directs: Darwin Platform Refineries Limited, Darwin Platform Industries Limited, Darwin Platform Infrastructure Limited and 5 more | Additional Director | 10 Oct 2023 | 3 Years 1 Months | Current |
| Vasu Kumar Also directs: Darwin Platform Capital Limited, Darwin Platform Logistics Limited, Darwin Platform Gold and Mining Limited and 5 more | Director | 11 Jun 2021 | 5 Years 5 Months | Current |
| Rahul Jeewanlal Dhote | Director | 05 Mar 2020 | 6 Years 8 Months | Current |
| Herambha Mukund Naik Also directs: Darwin Platform Industries Limited, Darwin Platform Gold and Mining Limited, Darwin Platform1 News Limited and 3 more | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Darwin Platform Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Servocare Lifesciences Private Limited | ₹25.93 Cr (FY 2024) | 14.0% | Chandigarh, India | |||
| Asle Pharmaceuticals Private Limited | ₹25.9 Cr (FY 2025) | 7.0% | Jaipur, Rajasthan, India | |||
| Keshava Medi Devices Private Limited | ₹25.84 Cr (FY 2025) | 5.0% | Tirupati, Andhra Pradesh, India | |||
| Darwin Platform Pharmaceuticals Limitedthis company | ₹25.84 Cr (FY 2024) | ₹57.73 Lakh | 2.2% | Mumbai, Maharashtra, India | ||
| Ether Pharmaceuticals Private Limited | ₹25.81 Cr (FY 2025) | 24.0% | Delhi, India | |||
| Traxo Medserve Private Limited | ₹25.73 Cr (FY 2024) | 0.0% | Ahmedabad, Gujarat, India | |||
| Krishaa Biotech Private Limited | ₹25.7 Cr (FY 2018) | 24.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Darwin Platform Pharmaceuticals Limited, buy the company report.
Auditor
Darwin Platform Pharmaceuticals Limited is audited by JAIN ANIL & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN ANIL & ASSOCIATES | FY 2020 | 115987W |
Shareholding
The shareholding of Darwin Platform Pharmaceuticals Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Darwin Platform Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 2023 | 100753428 | State Bank of India | ₹5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Darwin Platform Pharmaceuticals Limited has 5 court cases on record: 1 filed by Darwin Platform Pharmaceuticals, 4 filed against it. 3 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 3 | 2 |
| District courts | 1 | 1 | 1 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (AO) | Filed against the company by Darwin Platform Infrastructure Ltd. | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by Darwin Platform Force Limited | Pending |
| Bombay High Court | Court case (AO) | Filed by the company against State Bank of India | Pending |
| Bombay High Court | Court case (AO) | Filed against the company by State Bank of India | Disposed |
To see the full case history of Darwin Platform Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Darwin Platform Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Darwin Platform Pharmaceuticals Limited has 1 active EPFO establishment as of Nov 16, 2026.
GST
Darwin Platform Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECD3888N1ZY | Maharashtra | Active | 13 Mar 2020 |
To see the full GST registrations and return filing status of Darwin Platform Pharmaceuticals Limited, buy the company report.
Recent activity
Darwin Platform Pharmaceuticals Limited has 15 board changes on record since 2012: 4 appointments and 11 cessations. The latest: Manoj Pincha was appointed as Additional Director on 10 Oct 2023.
7 earlier events are in the company report.
Frequently asked questions
Darwin Platform Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 03 September 2012 (14+ years old) and is registered under CIN U85191MH2012PLC235261.
Darwin Platform Pharmaceuticals has 4 current directors:
- Manoj Pincha - Additional Director
- Vasu Kumar - Director
- Rahul Jeewanlal Dhote - Director
- Herambha Mukund Naik - Director
The latest financial statements of Darwin Platform Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Darwin Platform Pharmaceuticals is 27AAECD3888N1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Darwin Platform Pharmaceuticals is U85191MH2012PLC235261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Darwin Platform Pharmaceuticals has 5 court cases on record: 1 filed by the company and 4 filed against it. 3 are pending. Most are in the high courts.
Darwin Platform Pharmaceuticals was incorporated on 03 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Darwin Platform Pharmaceuticals by revenue are Servocare Lifesciences Private Limited, Asle Pharmaceuticals Private Limited, Keshava Medi Devices Private Limited, Ether Pharmaceuticals Private Limited, Traxo Medserve Private Limited and 1 more, all in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Manoj Pincha was appointed as Additional Director on 10 Oct 2023. Rahul Jeewanlal Dhote ceased to be Additional Director on 30 Nov 2021. Vasu Kumar ceased to be Additional Director on 30 Nov 2021. Darwin Platform Pharmaceuticals has 15 board changes on record in total.
Yes, Darwin Platform Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0070245).
Darwin Platform Pharmaceuticals can be reached through the website darwinpharma.in. Its registered office is in Mumbai, Maharashtra, India.

